Evidence map›Paper›PMID 35073742›Full record

ArticlemBio2022

Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins.

Jonathan P Richardson, Rhys Brown, Nessim Kichik, Sejeong Lee, Emily Priest, Selene Mogavero, Corinne Maufrais, Don N Wickramasinghe, Antzela Tsavou, Natalia K Kotowicz and 9 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 68 citations in OpenAlex.

  1. Microorganisms · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Aerolysin-like proteins fromFrontiers in fungal biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Commensal colonization ofMicrobiology spectrum · 2025
    Article
  13. Review
  14. Article
  15. Antifungal Activity of 5-Fluorouridine AgainstMolecules (Basel, Switzerland) · 2025
    Article
  16. Mycobiome: an underexplored kingdom in cancer.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  17. Review
  18. Infection and immunity · 2025
    Article
  19. Microorganisms · 2025
    Review
  20. Gut microbiome and liver diseases.Fundamental research · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 3 countries.

Jonathan P Richardson *Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.ORCID 0000-0001-9638-2725
Rhys Brown *Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Nessim KichikCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Sejeong LeeCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.ORCID 0000-0001-8617-3436
Emily PriestCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Selene MogaveroDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.ORCID 0000-0003-0642-0068
Corinne MaufraisInstitut Pasteurgrid.428999.7, Université de Paris, Bioinformatics and Biostatistics Hub, Paris, France.
Don N WickramasingheCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Antzela TsavouCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Natalia K KotowiczCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Olivia W HepworthCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Ana Gallego-CortésCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Nicole O PondeCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Jemima HoCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
David L MoyesCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
Duncan WilsonMedical Research Council Centre for Medical Mycology at the University of Exetergrid.8391.3, Exeter, United Kingdom.
Christophe D'EnfertInstitut Pasteurgrid.428999.7, Université de Paris, INRAE, USC2019, Unité Biologie et Pathogénicité Fongiques, Paris, France.ORCID 0000-0002-6235-3886
Bernhard HubeDepartment of Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knoell Institute, Jena, Germany.ORCID 0000-0002-6028-0425
Julian R NaglikCentre for Host-Microbiome Interactions, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
King's College London · GBInstitut Pasteur · FRLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEUniversity of Exeter · GB

Funding

Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6M
IL-17 Receptor Signaling in the Oral MucosaR01DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2012 to 2016
$2.1M
Biotechnology and Biological Sciences Research Council BB/N014677/1Medical Research Council MR/N006364/2Medical Research Council MR/V033417/1NIDCR NIH HHS R01 DE022550NIDCR NIH HHS R37 DE022550Wellcome TrustWellcome Trust 214229_Z_18_ZWellcome Trust 214317/A/18/ZWellcome Trust 215599/Z/19/Z
6 · The paper itself

Abstract

Candidalysin is the first cytolytic peptide toxin identified in any human fungal pathogen. Candidalysin is secreted by Candida albicans and is critical for driving infection and host immune responses in several model systems. However,

Indexed as

MycotoxinsCalciumCandidaCandida albicansCandida tropicalisCytokinesFungal ProteinsHumansPeptidesCalciumCytokinesECE1 protein, Candida albicansFungal ProteinsMycotoxinsPeptidesCandidacandidalysinfunguspeptide toxin

Identifiers

PMID35073742
PMCPMC8787473
OpenAlexW4206987565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.